Literature DB >> 16161159

Visual rating of white matter hyperintensities in Parkinson's disease.

Mona K Beyer1, Dag Aarsland, Ole Jacob Greve, Jan P Larsen.   

Abstract

Dementia is a common complication of Parkinson's disease (PD), but the cause is incompletely understood. In previous studies, dementia has been associated with an increase in hyperintense lesions in the cerebral white matter. The aim of this study was to explore whether white matter hyperintensities (WMH) on cerebral magnetic resonance imaging (MRI) are associated with dementia in PD. For this study, 35 patients with PD, 16 with dementia (PDD) and 19 without (PDND), and 20 control subjects were recruited. MRI scans of patients and controls were rated for WMH, blind to diagnosis, using the Scheltens visual rating scale. Both bivariate and multivariate statistical analyses were carried out. Cerebrovascular risk factors, education, gender, or age were similar across groups. Compared with the PDND group, the PDD group had significantly higher level of WMH in the deep white matter and in the periventricular areas. WMH in the deep white matter was the only variable that was associated significantly with Mini-Mental State Examination score and explained 38% of the variance in the multivariate linear regression analysis. Our findings suggest that WMH in the deep white matter may contribute to dementia in PD. Copyright (c) 2005 Movement Disorder Society.

Entities:  

Mesh:

Year:  2006        PMID: 16161159     DOI: 10.1002/mds.20704

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  30 in total

1.  An update on brain imaging in parkinsonian dementia.

Authors:  Myria Petrou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Imaging Med       Date:  2012-04

2.  Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease.

Authors:  J D Jones; I Malaty; C C Price; M S Okun; D Bowers
Journal:  Parkinsonism Relat Disord       Date:  2012-07-07       Impact factor: 4.891

Review 3.  The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Authors:  Branislav Veselý; Angelo Antonini; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2015-10-19       Impact factor: 3.575

4.  Cognitive status correlates with white matter alteration in Parkinson's disease.

Authors:  Takaaki Hattori; Satoshi Orimo; Shigeki Aoki; Kenji Ito; Osamu Abe; Atsushi Amano; Ryo Sato; Kasumi Sakai; Hidehiro Mizusawa
Journal:  Hum Brain Mapp       Date:  2011-04-14       Impact factor: 5.038

5.  Patterns of chronic venous insufficiency in the dural sinuses and extracranial draining veins and their relationship with white matter hyperintensities for patients with Parkinson's disease.

Authors:  Manju Liu; Haibo Xu; Yuhui Wang; Yi Zhong; Shuang Xia; David Utriainen; Tao Wang; E Mark Haacke
Journal:  J Vasc Surg       Date:  2014-03-19       Impact factor: 4.268

Review 6.  Management of Parkinson's disease dementia : practical considerations.

Authors:  Arvid Rongve; Dag Aarsland
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 7.  White matter lesions in Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

8.  A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry.

Authors:  Mona K Beyer; Carmen C Janvin; Jan P Larsen; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-06       Impact factor: 10.154

9.  Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease.

Authors:  Flavio Nobili; Dario Arnaldi; Claudio Campus; Michela Ferrara; Fabrizio De Carli; Andrea Brugnolo; Barbara Dessi; Nicola Girtler; Silvia Morbelli; Giovanni Abruzzese; Gianmario Sambuceti; Guido Rodriguez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-09       Impact factor: 9.236

10.  Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease.

Authors:  Mona K Beyer; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Yi-Yu Chou; Turi O Dalaker; Martin W Kurz; Jan P Larsen; Johanne H Somme; Paul M Thompson; Ole-Bjørn Tysnes; Liana G Apostolova
Journal:  Mov Disord       Date:  2013-02-13       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.